M
Martin Fugère
Researcher at Université de Sherbrooke
Publications - 14
Citations - 634
Martin Fugère is an academic researcher from Université de Sherbrooke. The author has contributed to research in topics: Furin & Proprotein Convertases. The author has an hindex of 9, co-authored 14 publications receiving 603 citations.
Papers
More filters
Journal ArticleDOI
TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity.
Nadim Srour,Annie Lebel,Stephanie McMahon,Isabelle Fournier,Martin Fugère,Robert Day,Claire M. Dubois +6 more
TL;DR: It is concluded that furin, in addition to other candidate PCs, is involved in TACE maturation and activation.
Journal ArticleDOI
Targeting Host Cell Furin Proprotein Convertases as a Therapeutic Strategy against Bacterial Toxins and Viral Pathogens
Sergey A. Shiryaev,Albert G. Remacle,Boris I. Ratnikov,Nicholas A. Nelson,Alexei Y. Savinov,Ge Wei,Massimo Bottini,Michele F. Rega,Amelie Parent,Roxane Desjardins,Martin Fugère,Robert Day,Mojgan Sabet,Maurizio Pellecchia,Robert C. Liddington,Jeffrey W. Smith,Tomas Mustelin,Donald G. Guiney,Michal Lebl,Alex Y. Strongin +19 more
TL;DR: In this paper, the authors designed specific nanomolar inhibitors of PC modeled from the extended cleavage motif TPQRERRRKKR downward arrow of the avian influenza H5N1 hemagglutinin.
Journal ArticleDOI
Furin processing and proteolytic activation of Semliki Forest virus.
TL;DR: Studies of unprocessed virus produced in FD11 cells (wt/p62) demonstrated that the p62 protein was efficiently cleaved by purified furin in vitro, without requiring prior exposure to low pH.
Journal ArticleDOI
Inhibitory Potency and Specificity of Subtilase-like Pro-protein Convertase (SPC) Prodomains
Martin Fugère,Polizois C. Limperis,Véronique Beaulieu-Audy,Frederic Gagnon,Pierre Lavigne,Klaus Klarskov,Richard Leduc,Robert Day +7 more
TL;DR: This study investigated the specificity and potency of complete prodomains and short C-terminal prodomain peptides of each SPC on highly purified, soluble enzyme preparations of human SPC1, SPC6, and SPC7, and demonstrated that the use of proDomains as specific inhibitors acting in trans would be of limited usefulness, unless modified into more specific compounds.
Journal ArticleDOI
Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: Use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences.
TL;DR: It is concluded that basic residues within PC peptide inhibitors might be responsible for targeting PCs in general and for inhibitory potency, but that select amino acid changes will be necessary to acquire true specificity toward a single PC.